Coagulation and Hemophilia Flashcards

1
Q

Hemophilia C is the deficiency in which Factor

A

Factor XI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Go through Intrinsic coagulation cascade

A

Contact activators (Prekallikrein and HMWK), then XII, XI, IX, and X (using VIIIa as a cofactor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why can patients with Factor XII and factor XI deficiencies have no bleeding phenotype?

A

Thrombin has a positive feedback (“thrombin burst”) that increases activation of XI and VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does the DRVVT test work? If it’s positive, what does that suggest?

A

Directly activates X to Xa, then goes through the rest of the common pathway. If time is prolonged, then test is repeated with and without phospholipid. If the ratio (PL/no PL) is prolonged, it’s indicative of antiphospholipid antibody.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the use of the reptilase time? (two things it is useful for)

A

Low fibrinogen
Dysfunctional fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factor deficiencies (3) are clinically silent but will prolong PTT?

A

HMWK and prekallikrien
Factor XII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the factor cutoffs for mild, moderate, and severe Hemophilia?

A

Mild: 5-40%
Moderate: 1-5%
Severe: <1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1 u/kg of Factor VIII raises blood levels by how much?

A

2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

1 u/kg of Factor IX raises blood levels by how much?

A

0.75-1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Goal factor levels for hemophilia patient with CNS bleed

A

80-100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Goal factor levels for hemophilia patient with major surgery

A

80-100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Goal factor levels for hemophilia patient with RP, epiglottis, floor of mouth bleed

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Goal factor levels for hemophilia patient with joint, muscle, GI tract, epistaxis, or hematuria

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does DDAVP work to help bleeding in hemophilia?

A

It releases endogenous Factor VIII:vWF complexes from endothelia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of action of Emicizumab

A

Binds to FIXa and FX to simulate the activity of Factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What medication can you NOT give Emicizumab with and why?

A

FEIBA because it causes a TMA

17
Q

You see a isolated prolonged PTT that fails to fully correct at a mixing study, and re-prolongs after incubation at 1-2 hours. What does this indicate?

A

Pathognomonic for a factor inhibitor - but the re-prolongation isn’t always present

18
Q

Three prongs to treating acquired hemophilia A due to an inhibitor?

A
  1. Increase Factor VIII levels with recombinant porcine FVIII (Obizur)
  2. Use bypassing agents like recombinant FVIIa or aPCC
  3. Eradicate the inhibitor with Rituximab or prednisone +/- cyclophosphamide
19
Q

What group of disorders is most closely associated with Factor V deficiency?

A

MPNs

20
Q

You see a bleeding patient with a history of essential thrombocythemia with prolonged PTT, prolonged INR, normal thrombin time, normal reptilase time. Diagnosis?

A

Factor V deficiency

21
Q

You see a bleeding patient with a history of essential thrombocythemia with prolonged PTT, prolonged INR, normal thrombin time, normal reptilase time. Diagnosis and Treatment?

A

Factor V deficiency
FFP to keep Factor V above 20%
(could also give platelets since FV is in platelet granules)

22
Q

Goal Factor V levels in a bleeding patient with FV deficiency?

A

20%

23
Q

You see a bleeding patient with a history of AL amyloidosis who has a prolonged PTT, prolonged INR, normal thrombin time, normal reptilase time. The PTT and INR corrects with mixing study. Diagnosis and treatment (two options)?

A

Factor X deficiency
Replace FX with recombinant X or PCC

24
Q

Patient seen with post-surgical bleeding and also incidentally noted LLE below knee DVT. Coags show prolonged INR, normal PTT, normal thrombin time, normal reptilase time. What is most likely diagnosis? Treatment (two options)

A

Factor VII deficiency
Recombinant FVII and antifibrinolytics

25
Q

Older patient presents with post-surgical bleeding. Coags show prolonged PTT and normal PT/INR. Factor VIII and IX levels are normal. What is most likely diagnosis? Treatment?

A

Factor XI deficiency (Hemophilia C)
FFP to increase FXI levels, also antifibrinolytics

26
Q

Patient presents with surgical site bleeding on POD 4. Coags show normal PT and PTT. Normal platelet studies. Clot stability assay shows clot that readily dissolves in urea. What’s most likely diagnosis?

A

Factor XIII deficiency

27
Q

In a clot stability assay, the lab adds Ca to plasma to cause a clot, then incubates and placed in 5M urea. If the clot dissolves, what disorder is that indicative of?

A

Factor XIII deficiency

28
Q

If a patient with Factor XIII deficiency is pregnant, how do you manage it?

A

Give recombinant FXIII by five weeks gestational age to maintain levels above 10%

29
Q

At what level of Factor XIII do you give prophylactic recombinant FXIII?

A

Less than 10%

30
Q

Prolonged reptilase time is indicative of what disorders?

A

Dysfibrinogenemia or hypofibrinogenemia

31
Q

In HHT, what is the inheritance pattern and what genes are commonly seen mutated?

A

AD, TGF-B pathway

32
Q

Diagnostic criteria for HHT (4)

A

Telangectasias on mucocutaneous sites, face, ears, fingertips
Recurrent epistaxis
Visceral AVMs
Family history of HHT

33
Q

Treatment of mild bleeding in HHT?

A

Antifibrinolytics

34
Q

Treatment of severe bleeding in HHT? Aside from local procedures

A

Antiangiogenics (Bevacizumab)